Figure 1From: Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical studyPercentage of patients within recommended antithrombotic range after (a) 1 × 3,000 IU/d, and (b) 2 × 3,000 IU/d certoparin.Back to article page